» Articles » PMID: 28581513

KIF26B, a Novel Oncogene, Promotes Proliferation and Metastasis by Activating the VEGF Pathway in Gastric Cancer

Overview
Journal Oncogene
Date 2017 Jun 6
PMID 28581513
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor metastasis is the main reason of cancer-related death for gastric cancer (GC) patients and gene expression microarray data indicate that kinesin family member 26B (KIF26B) is one of the most upregulated genes in metastatic GC samples. Specifically, KIF26B expression was upregulated in a stepwise manner from non-tumorous gastric mucosa, primary GC tissues without metastasis, via primary GC tissues with metastasis, to secondary lymph node metastatic (LNM) foci. Increased expression of KIF26B was correlated with tumor size, positive LNM or distant metastases and poor prognosis. KIF26B, negatively regulated by miR-372, promoted GC cell proliferation and metastasis in vitro and in vivo. Mechanistic investigations confirmed that the main target of KIF26B was the vascular endothelial growth factor (VEGF) signaling pathway, particularly by inhibition or overexpression of VEGFA, PXN, FAK, PIK3CA, BCL2 and CREB1. Thus, KIF26B, a novel oncogene regulated by miR-372, promotes proliferation and metastasis through the VEGF pathway in GC.

Citing Articles

Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression.

Saadh M, Ghnim Z, Mahdi M, Chandra M, Ballal S, Bareja L J Mol Neurosci. 2025; 75(1):10.

PMID: 39847238 DOI: 10.1007/s12031-025-02308-9.


Identification of Vesicle-Mediated Transport-Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer.

Lou S, Lv H, Zhang L Immun Inflamm Dis. 2024; 12(11):e70052.

PMID: 39513664 PMC: 11544644. DOI: 10.1002/iid3.70052.


Kinesin 26B modulates M2 polarization of macrophage by activating cancer-associated fibroblasts to aggravate gastric cancer occurrence and metastasis.

Huang L, Zhang M World J Gastroenterol. 2024; 30(20):2689-2708.

PMID: 38855156 PMC: 11154681. DOI: 10.3748/wjg.v30.i20.2689.


KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.

Zhong Q, Hong W, Xiong L Aging (Albany NY). 2024; 16(7):6163-6187.

PMID: 38552217 PMC: 11042961. DOI: 10.18632/aging.205694.


The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.

Zhao K, Li X, Feng Y, Wang J, Yao W Biomark Res. 2024; 12(1):30.

PMID: 38433242 PMC: 10910842. DOI: 10.1186/s40364-024-00559-z.


References
1.
Terabayashi T, Sakaguchi M, Shinmyozu K, Ohshima T, Johjima A, Ogura T . Phosphorylation of Kif26b promotes its polyubiquitination and subsequent proteasomal degradation during kidney development. PLoS One. 2012; 7(6):e39714. PMC: 3387196. DOI: 10.1371/journal.pone.0039714. View

2.
Fidler I . Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990; 50(19):6130-8. View

3.
Sakamoto K, Frank D . CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res. 2009; 15(8):2583-7. PMC: 2883446. DOI: 10.1158/1078-0432.CCR-08-1137. View

4.
Waller T, Gubala T, Sarapata K, Piwowar M, Jurkowski W . DNA microarray integromics analysis platform. BioData Min. 2015; 8:18. PMC: 4479227. DOI: 10.1186/s13040-015-0052-6. View

5.
Wang Q, Zhao Z, Wang G, Hui Z, Wang M, Pan J . High expression of KIF26B in breast cancer associates with poor prognosis. PLoS One. 2013; 8(4):e61640. PMC: 3621833. DOI: 10.1371/journal.pone.0061640. View